Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years

NCT01050257 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01050257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01050257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Lead sponsor
Hoffmann-La Roche
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2010
Completion date
September 30, 2012
Enrollment
118 (actual)
Sites
96

Conditions

As the registry lists them; a condition with its own page is linked.

influenza